363 related articles for article (PubMed ID: 22383796)
41. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
[TBL] [Abstract][Full Text] [Related]
42. Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3-ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.
Ofran Y; Leiba R; Frisch A; Horesh N; Henig I; Yehudai-Ofir D; Moshe Y; Neaman M; Ganzel C; Gal-Rabinovich K; Hellmann I; Weinstein V; Berger T; Wolach O
Eur J Haematol; 2021 Jan; 106(1):64-71. PubMed ID: 32949053
[TBL] [Abstract][Full Text] [Related]
43. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
[TBL] [Abstract][Full Text] [Related]
44. ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission.
Damiani D; Tiribelli M; Geromin A; Cerno M; Zanini F; Michelutti A; Fanin R
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1621-1626. PubMed ID: 27178373
[TBL] [Abstract][Full Text] [Related]
45. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
46. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
[TBL] [Abstract][Full Text] [Related]
47. Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
Juliusson G; Billström R; Gruber A; Hellström-Lindberg E; Höglunds M; Karlsson K; Stockelberg D; Wahlin A; Aström M; Arnesson C; Brunell-Abrahamsson U; Carstensen J; Fredriksson E; Holmberg E; Nordenskjöld K; Wiklund F;
Leukemia; 2006 Jan; 20(1):42-7. PubMed ID: 16327841
[TBL] [Abstract][Full Text] [Related]
48. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
49. Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation.
Ye P; Pei R; Jin J; Sun J; Li K; Cao J; Zhou D; Lu Y
Ann Hematol; 2019 Sep; 98(9):2073-2080. PubMed ID: 31201514
[TBL] [Abstract][Full Text] [Related]
50. Improved outcome in adult acute myeloid leukemia is almost entirely restricted to young patients and associated with stem cell transplantation.
Wahlin A; Markevärn B; Golovleva I; Nilsson M
Eur J Haematol; 2002 Jan; 68(1):54-63. PubMed ID: 11952822
[TBL] [Abstract][Full Text] [Related]
51. Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemia.
Appelbaum FR
Best Pract Res Clin Haematol; 2017 Dec; 30(4):320-326. PubMed ID: 29156203
[TBL] [Abstract][Full Text] [Related]
52. High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia.
Shacham-Abulafia A; Itchaki G; Yeshurun M; Paul M; Peck A; Leader A; Shpilberg O; Ram R; Raanani P
Acta Haematol; 2016; 135(1):55-64. PubMed ID: 26443995
[TBL] [Abstract][Full Text] [Related]
53. Introducing patient-reported outcome in the acute leukemia quality registries in Sweden.
Lennmyr EB; Karlsson K; Abrahamsson M; Ebrahim F; Lübking A; Höglund M; Juliusson G; Hallböök H
Eur J Haematol; 2020 Jun; 104(6):571-580. PubMed ID: 32080889
[TBL] [Abstract][Full Text] [Related]
54. Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study.
Kawashima N; Ishikawa Y; Atsuta Y; Sawa M; Ozawa Y; Hayashi M; Kohno A; Tomita A; Maeda T; Sakaida E; Usuki K; Hagihara M; Kanamori H; Matsuoka H; Kobayashi M; Asou N; Ohtake S; Matsumura I; Miyazaki Y; Naoe T; Kiyoi H;
Cancer Sci; 2020 Jul; 111(7):2472-2481. PubMed ID: 32391628
[TBL] [Abstract][Full Text] [Related]
55. Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.
Lorentino F; Labopin M; Bernardi M; Ciceri F; Socié G; Cornelissen JJ; Esteve J; Ruggeri A; Volin L; Yacoub-Agha I; Craddock C; Passweg J; Blaise D; Gedde-Dahl T; Poiani M; Fegueux N; Mohty M; Nagler A;
Am J Hematol; 2018 Oct; 93(10):1236-1244. PubMed ID: 30058714
[TBL] [Abstract][Full Text] [Related]
56. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
57. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
58. Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.
Yanada M; Takami A; Mizuno S; Mori J; Chou T; Usuki K; Uchiyama H; Amano I; Fujii S; Miyamoto T; Saito T; Kamimura T; Ichinohe T; Fukuda T; Okamoto S; Atsuta Y; Yano S
Int J Hematol; 2020 Jan; 111(1):93-102. PubMed ID: 31612307
[TBL] [Abstract][Full Text] [Related]
59. Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
Middeke JM; Herbst R; Parmentier S; Bug G; Hänel M; Stuhler G; Schäfer-Eckart K; Rösler W; Klein S; Bethge W; Bitz U; Büttner B; Knoth H; Alakel N; Schaich M; Morgner A; Kramer M; Sockel K; von Bonin M; Stölzel F; Platzbecker U; Röllig C; Thiede C; Ehninger G; Bornhäuser M; Schetelig J
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1491-1497. PubMed ID: 28527985
[TBL] [Abstract][Full Text] [Related]
60. Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting.
Nilsson C; Hulegårdh E; Garelius H; Möllgård L; Brune M; Wahlin A; Lenhoff S; Frödin U; Remberger M; Höglund M; Juliusson G; Stockelberg D; Lehmann S
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1770-1778. PubMed ID: 31176789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
